New 5W AI Visibility Index: Pharma Spends Billions on DTC Ads. The AI Engines Talk About Eli Lilly and Novo Nordisk Anyway

5W's release of the new AI Visibility Index, which finds that pharma spends billions on direct-to-consumer (DTC) ads, highlights a discrepancy between ad budgets and AI citation share. The index reveals that Eli Lilly and Novo Nordisk lead in AI discussions, despite not necessarily having the largest advertising budgets. This means that website owners in the pharmaceutical industry need to focus on creating content that patients are likely to self-research, rather than solely relying on advertising spend. As AI engines prioritize topics that are relevant to user queries, pharmaceutical companies must ensure their online presence is optimized for patient-driven searches. This shift in strategy can help companies like Merck increase their AI citation share and stay competitive in the market. To stay ahead, website owners should track AI bot traffic to their sites, monitoring which topics and keywords are driving engagement. They should also review and update their llms.txt files to ensure that AI engines can crawl and index their content effectively, particularly for patient-researched topics. Additionally, optimizing website content to address common patient queries can improve AI visibility and drive more relevant traffic to their sites.